Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin.
Saved in:
| Title: | Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin. |
|---|---|
| Authors: | Depau L; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Brunetti J; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Falciani C; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Mandarini E; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Zanchi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Paolocci MF; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Garfì M; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Pini A; Department of Medical Biotechnologies, University of Siena, Siena, Italy., Bracci L; Department of Medical Biotechnologies, University of Siena, Siena, Italy. |
| Source: | Frontiers in cell and developmental biology [Front Cell Dev Biol] 2025 Jan 08; Vol. 12, pp. 1505680. Date of Electronic Publication: 2025 Jan 08 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
